THC range is the middle half of 16 public lab tests of Double Tap flower (2020–2022). Source: Cannlytics lab results, CC BY 4.0.
Double Tap is an indica-leaning strain. People who try it most often describe feeling sleepy, talkative and relaxed.
Across 16 public lab tests of Double Tap flower between 2020 and 2022, the median result was 19.9% total THC, with half of all samples falling between 18.3% and 20.6%. CBD is typically negligible (under 0.5%). That is in line with most flower on dispensary shelves. Potency varies by grower and batch, so always check the label.
In lab tests its dominant terpene is caryophyllene, followed by limonene and humulene. Caryophyllene is known for black pepper and warm spice, while limonene adds bright citrus-peel freshness. Total terpene content measured a median of 1.9%. On the palate, people pick out tobacco, rose and pungent.
Beyond feeling sleepy, reviewers also mention feeling giggly and hungry. Some consumers say they reach for it when dealing with migraines, headaches and insomnia. The side effects mentioned most are dizziness, anxiety and dry mouth. These are personal reports, not medical advice.
Median share of flower weight in lab tests.
Matched on reported effects, terpenes and type.